| | Business Summary | | Advanced
Tobacco
Products,
Inc.,
doing
business
as
Advanced
Therapeutic
Products,
Inc.,
was
engaged
in
the
manufacturing
and
marketing
of
a
product
based
upon
nicotine
technology
through
September
1987.
In
1987,
ATP
sold
its
nicotine
technology
and
related
assets
to
what
is
now
known
as
Pharmacia
Corporation
(PHA),
a
worldwide
pharmaceutical
company
that
manufactures
the
Nicotrol/Nicorette
Inhaler
(Inhaler),
Nicorette
Chewing
Gum,
the
Nicotrol/Nicorette
Patch
and
the
Nicotrol/Nicorette
Nasal
Spray.
ATP
receives
product
payments
from
sales
of
the
Inhaler
outside
the
United
States
equal
to
3%
of
PHA's
net
sales
to
pharmacy
distributors.
ATP
also
has
an
agreement
with
PHA
under
which,
among
other
matters,
ATP
has
the
right
to
receive
a
royalty
equal
to
.1%
of
net
revenues
received
by
PHA
from
the
sale
of
any
product
using
a
nicotine
impermeable
copolymer
technology. | | More
from
Market Guide: Expanded
Business Description |
| | Financial Summary | | Advanced
Tobacco
Products
generates
revenues
through
the
receipt
of
royalty
payment
from
Pharmacia
Corp.
based
on
percentage
of
sales
of
products
using
a
nicotine
impermeable
copolymer
technology.
AVTH
currently
receives
royalties
from
sales
of
the
Nicotrol/Nicorette
patch.
For
the
nine
months
ended
6/30/01,
revenues
rose
29%
to
$501
thousand.
Net
income
rose
15%
to
$412
thousand.
Results
reflect
increased
payments
from
Pharmacia,
partially
offset
by
higher
administrative
costs. | | More
from
Market Guide: Significant
Developments |
| | |
| Position | | J. Linehan, 57 | Pres,
CEO, Chief Financial Officer, Sec. |
| More
from
Market Guide on Officers & Directors:
Expanded
List, Bios,
Compensation,
Options
|
|
![[one-year price graph]](http://chart.yahoo.com/c/0b/a/avth.ob.gif)